MRNA Moderna
Nasdaq · SEC CIK 1682852 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.63M 14 sales by 6 insiders
- Filings on record
- 574 since 2021-07-02, latest 2026-09-16 16:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bancel Stephane | CEO, Dir | — | $28.72M |
| Hoge Stephen | Pres | — | $28.43M |
| Mock James M | CFO | — | $4.69M |
| Klinger Shannon Thyme | CLO | — | $1.39M |
| AFEYAN NOUBAR | Dir | — | $1.14M |
| Hussain Abbas | Dir | — | $278.9K |
| Horning Sandra | Dir | — | — |
| NABEL ELIZABETH G | Dir | — | — |
| Rubenstein David M. | Dir | — | — |
| Nader Francois | Dir | — | — |
Transactions 1,002
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-05 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $111.44 | -115 | 6,634 | -2% | -$12.8K |
| D | 2023-09-06 | 2023-09-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +652 | 1.59M | +0.0% | — |
| D | 2023-09-06 | 2023-09-05 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $111.44 | -320 | 1.59M | -0.0% | -$35.7K |
| MT | 2023-09-01 | 2023-08-30 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $115.46 | -15.0K | 2.00M | -0.7% | -$1.73M |
| D | 2023-08-30 | 2023-08-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,411 | 1.59M | +0.2% | — |
| D | 2023-08-30 | 2023-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $115.01 | -1,135 | 1.59M | -0.1% | -$130.5K |
| MT | 2023-08-25 | 2023-08-23 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $115.51 | -15.0K | 2.02M | -0.7% | -$1.73M |
| MT | 2023-08-18 | 2023-08-16 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $97.56 | -10.0K | 2.03M | -0.5% | -$975.6K |
| 2023-08-18 | 2023-08-17 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15.0K | 1.59M | -0.9% | -$1.50M | |
| D | 2023-08-11 | 2023-08-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +523 | 1.60M | +0.0% | — |
| D | 2023-08-11 | 2023-08-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $102.53 | -247 | 1.60M | -0.0% | -$25.3K |
| MT | 2023-08-04 | 2023-08-02 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $110.99 | -15.0K | 2.04M | -0.7% | -$1.66M |
| MT | 2023-07-28 | 2023-07-26 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $120.42 | -15.0K | 2.06M | -0.7% | -$1.81M |
| MT | 2023-07-21 | 2023-07-19 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $125.48 | -15.0K | 2.07M | -0.7% | -$1.88M |
| 2023-07-18 | 2023-07-17 | MRNA | Hoge Stephen | Pres | S - Sale | $120.60 | -15.0K | 1.60M | -0.9% | -$1.81M | |
| MT | 2023-07-14 | 2023-07-12 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $125.81 | -15.0K | 2.08M | -0.7% | -$1.89M |
| M | 2023-07-07 | 2023-07-05 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $124.73 | -15.0K | 2.10M | -0.7% | -$1.87M |
| DM | 2023-06-30 | 2023-06-28 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $121.63 | -27.2K | 5.41M | -0.5% | -$3.30M |
| D | 2023-06-30 | 2023-06-28 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +27.2K | 5.44M | +0.5% | +$26.9K |
| MT | 2023-06-30 | 2023-06-28 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $121.54 | -15.0K | 2.11M | -0.7% | -$1.82M |
| DM | 2023-06-23 | 2023-06-21+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-06-23 | 2023-06-21+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $120.70 | -80.0K | 5.41M | -1% | -$9.66M |
| MT | 2023-06-23 | 2023-06-21 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $121.95 | -15.0K | 2.13M | -0.7% | -$1.83M |
| 2023-06-16 | 2023-06-15 | MRNA | Hoge Stephen | Pres | S - Sale | $125.93 | -15.0K | 1.62M | -0.9% | -$1.89M | |
| DM | 2023-06-16 | 2023-06-14+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-06-16 | 2023-06-14+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $127.27 | -80.0K | 5.41M | -1% | -$10.18M |
| M | 2023-06-16 | 2023-06-14 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $126.17 | -15.0K | 2.15M | -0.7% | -$1.89M |
| DM | 2023-06-09 | 2023-06-07+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-06-09 | 2023-06-07+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $124.91 | -80.0K | 5.43M | -1% | -$9.99M |
| D | 2023-06-09 | 2023-06-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $124.09 | -565 | 6,516 | -8% | -$70.1K |
| D | 2023-06-09 | 2023-06-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 7,081 | +19% | — |
| M | 2023-06-09 | 2023-06-07 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $125.91 | -15.0K | 2.16M | -0.7% | -$1.89M |
| D | 2023-06-07 | 2023-06-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | — | +4,562 | 4,837 | +1,659% | — |
| D | 2023-06-07 | 2023-06-06 | MRNA | Garay Arpa | Chief Commercial Off | S - Sale+OE | $125.75 | -2,290 | 2,547 | -47% | -$288.0K |
| D | 2023-06-05 | 2023-06-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.63M | +0.0% | — |
| D | 2023-06-05 | 2023-06-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $130.32 | -309 | 1.63M | -0.0% | -$40.3K |
| D | 2023-06-05 | 2023-06-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 6,052 | +4% | — |
| D | 2023-06-05 | 2023-06-02 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $130.32 | -110 | 5,942 | -2% | -$14.3K |
| M | 2023-06-02 | 2023-05-31 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $127.35 | -15.0K | 2.18M | -0.7% | -$1.91M |
| DM | 2023-06-02 | 2023-05-31+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $127.44 | -80.0K | 5.41M | -1% | -$10.20M |
| DM | 2023-06-02 | 2023-05-31+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2023-05-31 | 2023-05-26 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,410 | 1.63M | +0.1% | — |
| D | 2023-05-31 | 2023-05-30 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $124.95 | -1,181 | 1.63M | -0.1% | -$147.6K |
| DM | 2023-05-26 | 2023-05-24+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-05-26 | 2023-05-24+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $129.40 | -80.0K | 5.41M | -1% | -$10.35M |
| DM | 2023-05-19 | 2023-05-17+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $124.55 | -80.0K | 5.45M | -1% | -$9.96M |
| DM | 2023-05-19 | 2023-05-17+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-05-12 | 2023-05-10+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $129.43 | -80.0K | 5.41M | -1% | -$10.35M |
| DM | 2023-05-12 | 2023-05-10+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2023-05-11 | 2023-05-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $133.37 | -250 | 1.63M | -0.0% | -$33.3K |
| D | 2023-05-11 | 2023-05-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +522 | 1.63M | +0.0% | — |
| DM | 2023-05-05 | 2023-05-03+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $133.50 | -80.0K | 5.44M | -1% | -$10.68M |
| DM | 2023-05-05 | 2023-05-03+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| D | 2023-05-01 | 2023-04-28 | MRNA | Berenson Stephen | Dir | M - OptEx | — | +670 | 21.5K | +3% | — |
| D | 2023-05-01 | 2023-04-28 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | — | +670 | 1,373 | +95% | — |
| D | 2023-05-01 | 2023-04-28 | MRNA | Horning Sandra | Dir | M - OptEx | — | +670 | 1,373 | +95% | — |
| DM | 2023-04-28 | 2023-04-26+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-04-28 | 2023-04-26+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $131.17 | -80.0K | 5.41M | -1% | -$10.49M |
| DM | 2023-04-21 | 2023-04-19+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-04-21 | 2023-04-19+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $142.94 | -80.0K | 5.44M | -1% | -$11.43M |
| DM | 2023-04-14 | 2023-04-12+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $158.72 | -80.0K | 5.42M | -1% | -$12.70M |
| DM | 2023-04-14 | 2023-04-12+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-04-07 | 2023-04-05+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $156.06 | -80.0K | 5.45M | -1% | -$12.48M |
| DM | 2023-04-07 | 2023-04-05+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-31 | 2023-03-29+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $148.49 | -80.0K | 5.41M | -1% | -$11.88M |
| DM | 2023-03-31 | 2023-03-29+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-24 | 2023-03-22+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $149.72 | -80.0K | 5.41M | -1% | -$11.98M |
| DM | 2023-03-24 | 2023-03-22+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-17 | 2023-03-15+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $149.84 | -80.0K | 5.42M | -1% | -$11.99M |
| DM | 2023-03-17 | 2023-03-15+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-10 | 2023-03-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-10 | 2023-03-08+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $140.29 | -80.0K | 5.41M | -1% | -$11.22M |
| D | 2023-03-09 | 2023-03-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +1,138 | 6,381 | +22% | $0 |
| D | 2023-03-09 | 2023-03-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $141.51 | -561 | 5,820 | -9% | -$79.4K |
| DM | 2023-03-03 | 2023-03-01+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-03 | 2023-03-01+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $136.34 | -80.0K | 5.41M | -1% | -$10.91M |
| 2023-03-03 | 2023-03-01 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $139.00 | -10.0K | 2.19M | -0.5% | -$1.39M | |
| D | 2023-03-03 | 2023-03-02 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $136.43 | -459 | 5,243 | -8% | -$62.6K |
| D | 2023-03-03 | 2023-03-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +930 | 5,702 | +19% | $0 |
| D | 2023-03-03 | 2023-03-01 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,606 | 1.63M | +0.2% | $0 |
| D | 2023-03-03 | 2023-03-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $136.43 | -1,177 | 1.63M | -0.1% | -$160.6K |
| D | 2023-03-02 | 2023-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,410 | 1.63M | +0.1% | $0 |
| D | 2023-03-02 | 2023-03-01 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $138.03 | -1,072 | 1.63M | -0.1% | -$148.0K |
| 2023-02-24 | 2023-02-22 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $160.35 | -10.0K | 2.20M | -0.5% | -$1.60M | |
| DM | 2023-02-24 | 2023-02-22+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-02-24 | 2023-02-22+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $152.48 | -80.0K | 5.44M | -1% | -$12.20M |
| DM | 2023-02-17 | 2023-02-15+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $174.02 | -80.0K | 5.41M | -1% | -$13.92M |
| DM | 2023-02-17 | 2023-02-15+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| 2023-02-17 | 2023-02-15 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $173.17 | -10.0K | 2.21M | -0.5% | -$1.73M | |
| D | 2023-02-13 | 2023-02-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $163.90 | -245 | 1.63M | -0.0% | -$40.2K |
| D | 2023-02-13 | 2023-02-09 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +522 | 1.63M | +0.0% | $0 |
| DM | 2023-02-10 | 2023-02-08+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $165.79 | -80.0K | 5.41M | -1% | -$13.26M |
| DM | 2023-02-10 | 2023-02-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| M | 2023-02-10 | 2023-02-08 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $167.84 | -20.0K | 2.22M | -0.9% | -$3.36M |
| DM | 2023-02-03 | 2023-02-01+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $172.16 | -80.0K | 5.44M | -1% | -$13.77M |
| DM | 2023-02-03 | 2023-02-01+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-01-27 | 2023-01-25+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $191.38 | -80.0K | 5.41M | -1% | -$15.31M |
| DM | 2023-01-27 | 2023-01-25+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| 2023-01-27 | 2023-01-25 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $194.33 | -10.0K | 2.24M | -0.4% | -$1.94M | |
| DM | 2023-01-20 | 2023-01-18+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $195.01 | -80.0K | 5.41M | -1% | -$15.60M |
Purchase Sale Sale after option exercise All abbreviations